Equities

THE BIG QUESTION

PRIVATE EQUITY

CHINA

Nathan Sweeney, senior investment manager at Architas, says the UK recovery is gaining traction, although several global threats remain.

Newton Managed Income

The "brutal" sell-off which has hit emerging markets for six since the start of the year is now at an end, Aberdeen CEO Martin Gilbert has said, with outflows from the group's fund range slowing.

Searching for income further afield

Aberdeen has reported £8.8bn in net outflows for the six months to 31 March 2014 despite redemptions slowing in the final month of the period.

Pfizer, the US pharmaceuticals giant which today raised its offer for UK rival AstraZeneca, has written to Prime Minister David Cameron in an attempt to appease fears over the impact of any takeover.

US giant Pfizer has made an improved offer to buy AstraZeneca, the UK's second largest pharmaceuticals company, raising its bid to £50 a share.